These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
627 related articles for article (PubMed ID: 12628268)
1. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. Spencer K; Spencer CE; Power M; Dawson C; Nicolaides KH BJOG; 2003 Mar; 110(3):281-6. PubMed ID: 12628268 [TBL] [Abstract][Full Text] [Related]
2. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. Spencer K; Nicolaides KH BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267 [TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for fetal aneuploidy in singleton pregnancies. Chitayat D; Langlois S; Douglas Wilson R; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752 [TBL] [Abstract][Full Text] [Related]
4. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. Spencer K; Spencer CE; Power M; Moakes A; Nicolaides KH BJOG; 2000 Oct; 107(10):1271-5. PubMed ID: 11028580 [TBL] [Abstract][Full Text] [Related]
5. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening. Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371 [TBL] [Abstract][Full Text] [Related]
6. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks. Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277 [TBL] [Abstract][Full Text] [Related]
7. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399 [TBL] [Abstract][Full Text] [Related]
16. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies. Bindra R; Heath V; Liao A; Spencer K; Nicolaides KH Ultrasound Obstet Gynecol; 2002 Sep; 20(3):219-25. PubMed ID: 12230441 [TBL] [Abstract][Full Text] [Related]
17. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation]. Chen X; Chang Y; Cui HY; Ren CC; Yu BY Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556 [TBL] [Abstract][Full Text] [Related]
18. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening. Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311 [TBL] [Abstract][Full Text] [Related]
19. [OSCAR (one-stop clinic for assessment of fetal risk): our experience with first trimester screening for chromosomal abnormalities]. Dhaifalah I; Vrbická D; Santavý J Ceska Gynekol; 2006 Sep; 71(5):363-9. PubMed ID: 17131919 [TBL] [Abstract][Full Text] [Related]
20. Uptake of prenatal screening for chromosomal anomalies: impact of test results in a previous pregnancy. Spencer K Prenat Diagn; 2002 Dec; 22(13):1229-32. PubMed ID: 12478639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]